Back to Search
Start Over
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors.
- Source :
- Acta Orthopaedica; Feb2011, Vol. 82 Issue 1, p42-49, 8p, 6 Charts
- Publication Year :
- 2011
-
Abstract
- Background and purpose Thrombophilia represents a risk factor both for idiopathic and secondary osteonecrosis (ON). We evaluated whether clotting changes in idiopathic ON were different from corticosteroid-associated ON. As platelet-rich plasma has been proposed as an adjuvant in surgery, we also assessed whether platelet and serum growth factors were similar to those in healthy subjects. Methods 18 patients with idiopathic ON and 18 with corticosteroid-associated ON were compared with 44 controls for acquired and inherited thrombophilia. Platelet factor 4 (PF4), transforming growth factor- ββ1, platelet-derived growth factor-BB (PDGF-BB), and vascular endothelial growth factor were assayed in the supernatants of thrombin-activated platelets, in platelet lysates, and in serum from 14 ON patients and 10 controls. Results Idiopathic ON patients had higher plasminogen levels (median 118%) than controls (101%) (p == 0.02). Those with corticosteroid-associated ON had significantly higher D-dimer (333 ng/mL) and lower protein C levels (129%) than controls (164 ng/mL, p == 0.004; 160%, p == 0.02). The frequency of inherited thrombophilia was not different from the controls. No statistically significant differences were found between idiopathic and corticosteroid-associated ON. 20 of the 36 ON patients were smokers. (The controls were selected from smokers because nicotine favors hypercoagulability). ON patients had significantly higher serum PF4 levels (7,383 IU/mL) and PDGF-BB levels (3.1 ng/mL) than controls (4,697 IU/mL, p == 0.005; 2.2 ng/mL, p == 0.02). Interpretation Acquired hypercoagulability was common in both ON types, but the specific changes varied. The release of GF from platelets was not affected, providing a biological basis for platelet-rich plasma being used as an adjuvant in surgical treatment. [ABSTRACT FROM AUTHOR]
- Subjects :
- BLOOD platelets
ANALYSIS of variance
BLOOD diseases
BLOOD coagulation factors
OSTEONECROSIS
COMPUTER software
FEMUR
GENES
GENETIC polymorphisms
GROWTH factors
GENETIC mutation
RESEARCH funding
STATISTICS
U-statistics
STATISTICAL power analysis
DATA analysis
CASE-control method
DISEASE complications
PHYSIOLOGY
Subjects
Details
- Language :
- English
- ISSN :
- 17453674
- Volume :
- 82
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Acta Orthopaedica
- Publication Type :
- Academic Journal
- Accession number :
- 57821849
- Full Text :
- https://doi.org/10.3109/17453674.2011.555368